Gilles Montalescot Selected Research

Enoxaparin (Lovenox)

12/2018	Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin.
11/2017	Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures.
1/2017	Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial.
1/2016	Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
10/2015	Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial.
11/2013	A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).
7/2013	Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
6/2013	Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.
2/2012	Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis.
8/2011	Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Montalescot Research Topics

Disease

156	Myocardial Infarction 01/2022 - 01/2003
132	Hemorrhage 01/2022 - 10/2002
113	ST Elevation Myocardial Infarction 10/2022 - 01/2003
101	Acute Coronary Syndrome 11/2021 - 10/2002
80	Thrombosis (Thrombus) 01/2022 - 09/2005
55	Stroke (Strokes) 01/2022 - 01/2005
30	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 03/2004
29	Heart Failure 12/2019 - 01/2003
23	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2004
18	Ischemia 01/2018 - 04/2003
17	Cardiogenic Shock 10/2021 - 02/2007
13	Atrial Fibrillation 01/2021 - 01/2005
12	Infarction (Infarctions) 01/2021 - 04/2004
11	Renal Insufficiency (Renal Failure) 01/2020 - 12/2002
11	Non-ST Elevated Myocardial Infarction 01/2019 - 01/2003
9	Unstable Angina 05/2017 - 01/2003
8	Heart Arrest (Cardiac Arrest) 01/2018 - 10/2004
7	Diabetes Mellitus 10/2020 - 10/2005
7	Hypertension (High Blood Pressure) 01/2012 - 01/2003
6	Shock 09/2021 - 02/2016
6	Body Weight (Weight, Body) 03/2020 - 06/2004
6	Vascular Diseases (Vascular Disease) 01/2019 - 09/2005
6	Inflammation (Inflammations) 01/2019 - 04/2003
6	Peripheral Arterial Disease 11/2015 - 09/2005
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 10/2007
4	Chest Pain (Chest Pains) 04/2019 - 01/2006
4	Ventricular Tachycardia 01/2018 - 12/2009
3	COVID-19 01/2022 - 12/2020
3	Chronic Renal Insufficiency 10/2020 - 05/2009
3	Ventricular Fibrillation 01/2020 - 12/2006
3	Coronary Disease (Coronary Heart Disease) 01/2020 - 06/2009
3	Ischemic Stroke 07/2019 - 05/2007
3	Acute Kidney Injury (Acute Renal Failure) 03/2019 - 04/2009
3	Atherosclerosis 12/2018 - 10/2011
3	Hyperkalemia 01/2018 - 10/2010
3	Hematoma 01/2013 - 12/2009
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2012 - 12/2005

Drug/Important Bio-Agent (IBA)

68	Clopidogrel (Plavix)FDA Link 09/2021 - 01/2004
46	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2004
39	TicagrelorIBA 09/2021 - 06/2011
38	Prasugrel Hydrochloride FDA Link 10/2022 - 10/2006
35	Glycoproteins (Glycoprotein)IBA 01/2020 - 10/2002
29	Heparin (Liquaemin)FDA LinkGeneric 12/2018 - 04/2003
28	Enoxaparin (Lovenox)FDA LinkGeneric 12/2018 - 01/2003
16	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2021 - 06/2010
14	Pharmaceutical PreparationsIBA 01/2020 - 06/2007
13	AnticoagulantsIBA 01/2019 - 04/2007
12	omega-Chloroacetophenone (Mace)IBA 11/2021 - 07/2010
12	Platelet Membrane Glycoprotein IIbIBA 04/2019 - 10/2002
11	AldosteroneIBA 01/2022 - 12/2006
11	Biomarkers (Surrogate Marker)IBA 03/2019 - 09/2010
10	Cytochrome P-450 CYP2C19IBA 01/2020 - 01/2009
10	Abciximab (ReoPro)FDA Link 02/2012 - 03/2004
9	CreatinineIBA 03/2019 - 01/2003
9	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 10/2002
8	thienopyridineIBA 01/2020 - 01/2004
8	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 01/2004
8	Eptifibatide (Integrilin)FDA Link 04/2014 - 12/2002
6	TroponinIBA 11/2015 - 09/2006
5	apixabanIBA 01/2022 - 06/2009
5	Purinergic P2Y Receptor AntagonistsIBA 09/2021 - 09/2005
5	ThienopyridinesIBA 10/2014 - 01/2004
4	TabletsIBA 10/2022 - 01/2020
4	RivaroxabanIBA 01/2020 - 05/2017
4	Adenosine Diphosphate (ADP)IBA 04/2019 - 09/2006
4	Mineralocorticoid Receptor AntagonistsIBA 11/2018 - 12/2006
4	cangrelorIBA 04/2013 - 12/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2022 - 10/2008
3	ReninIBA 01/2022 - 12/2006
3	C-Reactive ProteinIBA 10/2020 - 04/2003
3	HDL CholesterolIBA 11/2019 - 08/2010
3	Morphine (MS Contin)FDA LinkGeneric 04/2019 - 01/2016
3	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 06/2010
3	Eplerenone (Inspra)FDA LinkGeneric 12/2018 - 09/2014
3	CollagenIBA 12/2018 - 10/2009
3	FibrinIBA 01/2017 - 03/2011
3	Streptokinase FDA Link 01/2016 - 12/2009
3	vasodilator-stimulated phosphoproteinIBA 11/2015 - 01/2013
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2013 - 09/2006
3	Irbesartan FDA LinkGeneric 09/2010 - 12/2005
3	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2010 - 10/2004
3	Biological ProductsIBA 04/2010 - 03/2009
3	reteplase FDA Link 02/2010 - 05/2008
2	LipidsIBA 09/2022 - 01/2017

Therapy/Procedure

128	Percutaneous Coronary Intervention 06/2022 - 10/2002
97	Therapeutics 09/2022 - 10/2002
72	Stents 01/2021 - 05/2006
20	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 01/2005
8	Secondary Prevention 09/2022 - 05/2007
7	Drug-Eluting Stents 04/2017 - 01/2006
7	Thrombolytic Therapy 11/2014 - 03/2005
5	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 02/2016
4	Blood Transfusion (Blood Transfusions) 06/2013 - 04/2005
3	Artificial Respiration (Mechanical Ventilation) 03/2020 - 11/2015
3	Resuscitation 03/2020 - 07/2013
3	Contraindications 01/2020 - 06/2010
3	Patient Readmission 11/2018 - 01/2012
2	Bioprosthesis 01/2022 - 01/2021
2	Duration of Therapy 02/2021 - 01/2019
2	Oral Administration 01/2021 - 06/2014